BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37690841)

  • 21. Medullary Thyroid Carcinoma: Do Ultrasonography and F-DOPA-PET-CT Influence the Initial Surgical Strategy?
    Brammen L; Niederle MB; Riss P; Scheuba C; Selberherr A; Karanikas G; Bodner G; Koperek O; Niederle B
    Ann Surg Oncol; 2018 Dec; 25(13):3919-3927. PubMed ID: 30306375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasonographic characteristics of medullary thyroid carcinoma: a comparison with papillary thyroid carcinoma.
    Liu MJ; Liu ZF; Hou YY; Men YM; Zhang YX; Gao LY; Liu H
    Oncotarget; 2017 Apr; 8(16):27520-27528. PubMed ID: 28460476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center.
    Kim SJ; Yun HJ; Shin SJ; Lee YS; Chang HS
    Front Endocrinol (Lausanne); 2021; 12():747704. PubMed ID: 34803914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early postoperative calcitonin-to-preoperative calcitonin ratio as a predictive marker for structural recurrence in sporadic medullary thyroid cancer: A retrospective study.
    Jiao Z; Wu T; Jiang M; Jiang S; Jiang K; Peng J; Luo G; Yu Y; Chen W; Yang A
    Front Endocrinol (Lausanne); 2022; 13():1094242. PubMed ID: 36589824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk and survival of patients with medullary thyroid cancer: National perspective.
    Al-Qurayshi Z; Khadra H; Chang K; Pagedar N; Randolph GW; Kandil E
    Oral Oncol; 2018 Aug; 83():59-63. PubMed ID: 30098780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High frequency ultrasound features and pathological characteristics of medullary thyroid carcinoma.
    Wang H; Liu M; Yang J; Song Y
    Pak J Pharm Sci; 2016 Nov; 29(6 Suppl):2269-2271. PubMed ID: 28167464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is Encapsulated Medullary Thyroid Carcinoma Associated With a Better Prognosis? A Case Series and a Review of the Literature.
    Contarino A; Dolci A; Maggioni M; Porta FM; Lopez G; Verga U; Elli FM; Iofrida EF; Cantoni G; Mantovani G; Arosio M
    Front Endocrinol (Lausanne); 2022; 13():866572. PubMed ID: 35574005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of the lateral neck compartment in patients with sporadic medullary thyroid cancer.
    Pena I; Clayman GL; Grubbs EG; Bergeron JM; Waguespack SG; Cabanillas ME; Dadu R; Hu MI; Fellman BM; Li Y; Gross ND; Lai SY; Sturgis EM; Zafereo ME
    Head Neck; 2018 Jan; 40(1):79-85. PubMed ID: 29044788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting Outcomes in Sporadic and Hereditary Medullary Thyroid Carcinoma over Two Decades.
    Kotwal A; Erickson D; Geske JR; Hay ID; Castro MR
    Thyroid; 2021 Apr; 31(4):616-626. PubMed ID: 33108969
    [No Abstract]   [Full Text] [Related]  

  • 30. The survival outcomes of prophylactic lateral neck dissection for medullary thyroid carcinoma, a retrospective cohort study.
    Hao W; Zhao J; Guo F; Zhang J; Gu P; Ruan X; Zhang W; Zheng X; Gao M
    Clin Otolaryngol; 2023 Sep; 48(5):734-739. PubMed ID: 37366234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postoperative biochemical remission of serum calcitonin is the best predictive factor for recurrence-free survival of medullary thyroid cancer: a large-scale retrospective analysis over 30 years.
    Jung KY; Kim SM; Yoo WS; Kim BW; Lee YS; Kim KW; Lee KE; Jeong JJ; Nam KH; Lee SH; Hah JH; Chung WY; Yi KH; Park DJ; Youn YK; Sung MW; Cho BY; Park CS; Park YJ; Chang HS
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):587-97. PubMed ID: 26175307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcitonin measurement in wash-out fluid from fine needle aspiration of neck masses in patients with primary and metastatic medullary thyroid carcinoma.
    Boi F; Maurelli I; Pinna G; Atzeni F; Piga M; Lai ML; Mariotti S
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2115-8. PubMed ID: 17405835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgery for lymph node metastases of medullary thyroid carcinoma: A review.
    Jin LX; Moley JF
    Cancer; 2016 Feb; 122(3):358-66. PubMed ID: 26539937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrasound features of medullary thyroid carcinoma correlate with cancer aggressiveness: a retrospective multicenter study.
    Trimboli P; Giovanella L; Valabrega S; Andrioli M; Baldelli R; Cremonini N; Rossi F; Guidobaldi L; Barnabei A; Rota F; Paoloni A; Rizza L; Fattorini G; Latini M; Ventura C; Falasca P; Orlandi F; Crescenzi A; D'Ambrosio F; Cantisani V; Romanelli F; Negro R; Saggiorato E; Appetecchia M
    J Exp Clin Cancer Res; 2014 Oct; 33(1):87. PubMed ID: 25344474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Static Prognostic Factors and Appropriate Surgical Designs for Patients with Medullary Thyroid Carcinoma: The Second Report from a Single-Institution Study in Japan.
    Ito Y; Miyauchi A; Kihara M; Higashiiyama T; Fukushima M; Miya A
    World J Surg; 2018 Dec; 42(12):3954-3966. PubMed ID: 30051240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of lymph node ratio as a prognostic factor of recurrence in medullary thyroid cancer.
    Hao W; Zhao J; Guo F; Gu P; Zhang J; Huang D; Ruan X; Zeng Y; Zheng X; Gao M
    PeerJ; 2023; 11():e15025. PubMed ID: 36935920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relevance of preoperative ultrasound cervical mapping in patients with thyroid cancer.
    Kocharyan D; Schwenter F; Bélair M; Nassif E
    Can J Surg; 2016 Apr; 59(2):113-7. PubMed ID: 27007092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The application value of modified thyroid imaging report and data system in diagnosing medullary thyroid carcinoma.
    Zhu J; Li X; Wei X; Yang X; Zhao J; Zhang S; Guo Z
    Cancer Med; 2019 Jul; 8(7):3389-3400. PubMed ID: 31070290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of risk factors for cervical lymph node metastases in patients with sporadic medullary thyroid carcinoma.
    Fan W; Xiao C; Wu F
    J Int Med Res; 2018 May; 46(5):1982-1989. PubMed ID: 29569965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid.
    Caobelli F; Chiaravalloti A; Evangelista L; Saladini G; Schillaci O; Vadrucci M; Scalorbi F; Donner D; Alongi P;
    Ann Nucl Med; 2018 Jan; 32(1):7-15. PubMed ID: 28986764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.